Mink Therapeutics, Inc. · NASDAQ:INKT
Holcomb John Bradley received 2,330 Mink Therapeutics, Inc. shares as an award (Form 4)
Traded Mar 2 to Jun 1, 2026 · Filed Jun 2, 2026
From Mar 2 to Jun 1, 2026, Holcomb John Bradley (Director) received 2,330 Mink Therapeutics, Inc. shares as an award at an average US$11.59 for US$27,012, leaving 3,458 shares. Filed Jun 2, 2026 (Form 4).
- Awarded
- 2,330 shares
- Price
- US$11.59 average (US$10.90 to US$12.38)
- Value
- US$27,012
- Holding after
- 3,458 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | Common Stock | Award | 1,239 | US$10.90 | 2,367 | Direct |
| Jun 1, 2026 | Common Stock | Award | 1,091 | US$12.38 | 3,458 | Direct |
Source
Related
- Mink Therapeutics, Inc.
- Holcomb John Bradley
- Mink Therapeutics, Inc. shareholders
- Form 4 · Holcomb John Bradley · Sep 2, 2026
- Form 4 · Buell Jennifer · Oct 14, 2026
- Form 4 · Wiinberg Ulf · Sep 2, 2026
- Form 4 · Behner Peter · Sep 2, 2026
- Form 4 · Ryan Barbara · Sep 2, 2026
- Form 4 · Corvese Brian · Sep 2, 2026